test

Dr. Jeffrey R. Jay, M.D.

@Great Point Partners Llc

Latest period2024 - Q3ReportedManaged Assets$339.762MTotal holdings29
Assets growth rate-34.91%Assets growth rate (2-Q avg)-26.77%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Great Point Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Great Point Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.762M in assets, with a quarterly growth rate of -34.91% and a 2-quarter average growth rate of -26.77%. The portfolio is managed by Dr. Jeffrey R. Jay, M.D., and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
INSMInsmed Inc
Recent Activity
Exited
0%
$16.75M
250,000 shares@ $67.0 avg price
FOLDAmicus Therapeutics Inc
Recent Activity
Exited
0%
$14.835M
1.496M shares@ $9.92 avg price
ESPREsperion Therapeutics Inc Ne
Recent Activity
Exited
0%
$12.857M
5.792M shares@ $2.23 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Exited
0%
$7.827M
1.149M shares@ $6.82 avg price
PBYIPuma Biotechnology Inc
Recent Activity
Exited
0%
$4.846M
1.487M shares@ $3.26 avg price
KYTXKyverna Therapeutics Inc
Recent Activity
Exited
0%
$3.744M
499,152 shares@ $7.5 avg price
SYRESpyre Therapeutics Inc
Recent Activity
Exited
0%
$3.165M
134,612 shares@ $23.51 avg price
ANABAnaptysbio Inc
Recent Activity
Exited
0%
$626,500
25,000 shares@ $25.06 avg price
LXRXLexicon Pharmaceuticals Inc
Recent Activity
Exited
0%
$50,400
30,000 shares@ $1.68 avg price